NeoGenomics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $1.11B | $316.8M |
| FY2022 | — | $998.0M | $263.2M |
| FY2023 | $538.2M | $941.5M | $342.5M |
| FY2024 | $340.3M | $902.3M | $367.0M |
| FY2025 | $341.9M | $836.6M | $159.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $1.11B | $316.8M |
| FY2022 | — | $998.0M | $263.2M |
| FY2023 | $538.2M | $941.5M | $342.5M |
| FY2024 | $340.3M | $902.3M | $367.0M |
| FY2025 | $341.9M | $836.6M | $159.6M |